Publication: Hepatic reduction of carbamoyl-PROXYL in ferric nitrilotriacetate induced iron overloaded mice: An in vivo ESR study
dc.contributor.author | Noppawan Phumala Morales | en_US |
dc.contributor.author | Yumiko Yamaguchi | en_US |
dc.contributor.author | Kimiyo Murakami | en_US |
dc.contributor.author | Nuttavut Kosem | en_US |
dc.contributor.author | Hideo Utsumi | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Kyushu University | en_US |
dc.date.accessioned | 2018-06-11T05:23:14Z | |
dc.date.available | 2018-06-11T05:23:14Z | |
dc.date.issued | 2012-07-01 | en_US |
dc.description.abstract | Reduction of a nitroxyl radical, carbamoyl-PROXYL in association of free radical production and hepatic glutathione (GSH) was investigated in iron overloaded mice using an in vivo L-band electron spin resonance (ESR) spectrometer. Significant increases in hepatic iron, lipid peroxidation and decrease in hepatic GSH were observed in mice intraperitoneally (i.p.) administrated with ferric nitrilotriacetate (Fe(III)-NTA, a total 45 μmol/mouse over a period of 3 weeks). Free radical production in iron overloaded mice was evidenced by significantly enhanced rate constant of ESR signal decay of carbamoyl-PROXYL, which was slightly reduced by treatment with iron chelator, deferoxamine. Moreover, the rate constant of ESR signal decay was negatively correlated with hepatic GSH level (r--=0.586, p < 0.001). On the other hand, hepatic GSH-depletion ( > 80%) in mice through daily i.p. injection and drinking water supplementation of L-buthionine-[ S,R]-sulfoximine (BSO) significantly retarded ESR signal decay, while there were no changes in serum aspartate aminotransferase and liver thiobarbituric acid-reactive substances levels. In conclusion, GSH plays two distinguish roles on ESR signal decay of carbamoyl-PROXYL, as an antioxidant and as a reducing agent, dependently on its concentration. Therefore, it should be taken into account in the interpretation of free radical production in each specific experimental setting. © 2012 The Pharmaceutical Society of Japan. | en_US |
dc.identifier.citation | Biological and Pharmaceutical Bulletin. Vol.35, No.7 (2012), 1035-1040 | en_US |
dc.identifier.doi | 10.1248/bpb.b110701 | en_US |
dc.identifier.issn | 13475215 | en_US |
dc.identifier.issn | 09186158 | en_US |
dc.identifier.other | 2-s2.0-84863543125 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/15162 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863543125&origin=inward | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Hepatic reduction of carbamoyl-PROXYL in ferric nitrilotriacetate induced iron overloaded mice: An in vivo ESR study | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863543125&origin=inward | en_US |